Ledger.Open graph →
SEC Form D · filed February 3, 2023

Garuda Therapeutics, Inc

Offering
$62.9M
Sold
$62.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Carl I. Gordon · Natick, MADirectorRaymond I. Kelleher · Cambridge, MADirectorDaniel I. Janse · Cambridge, MADirectorEric I. Aguiar · Natick, MADirectorDhvanit I. Shah · Natick, MAExec · DirectorRahul I. Singhvi · Natick, MADirectorLaurence I. Reid · Cambridge, MADirectorDaniel I. Janse · Cambridge, MADirectorEric I. Aguiar · Natick, MADirectorCarl I. Gordon · Natick, MADirectorDhvanit I. Shah · Natick, MAExec · DirectorRaymond I. Kelleher · Cambridge, MADirectorRahul I. Singhvi · Natick, MADirectorLaurence I. Reid · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗